Scientists initially believed that obesity drugs like Ozempic, Wegovy, Mounjaro and Zepbound worked by mimicking a hormone (GLP-1) that signals fullness and helps reduce appetite. However, recent research indicates that these medications are functioning in an unexpected way: by interacting with GLP-1 receptors in the brain that impact appetite and other desires. This new understanding could potentially lead to the development of more precise and effective drugs for treating obesity.
Identity Theft Surges as Criminals Deploy Advanced Tactics to Steal Personal Data
In 2024, identity theft surged, leading to over $16 billion in U.S. losses. Criminals exploit generative AI, deepfakes, and sophisticated phishing tactics, with synthetic identity
